My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
ARCHIVED REPORTS_2011 REVISED FEASABILITY STUDY
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
I
>
INDUSTRIAL
>
230
>
2900 - Site Mitigation Program
>
PR0009051
>
ARCHIVED REPORTS_2011 REVISED FEASABILITY STUDY
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/5/2020 2:26:35 PM
Creation date
2/5/2020 10:37:50 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
ARCHIVED REPORTS
FileName_PostFix
2011 REVISED FEASABILITY STUDY
RECORD_ID
PR0009051
PE
2960
FACILITY_ID
FA0000649
FACILITY_NAME
FORMER NESTLE USA INC FACILITY
STREET_NUMBER
230
STREET_NAME
INDUSTRIAL
STREET_TYPE
DR
City
RIPON
Zip
95366
APN
25938001
CURRENT_STATUS
01
SITE_LOCATION
230 INDUSTRIAL DR
P_LOCATION
05
P_DISTRICT
005
QC Status
Approved
Scanner
SJGOV\sballwahn
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
276
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Nestle USA, Inc.—Ripon, CA January 28, 2011 <br /> 2011 Revised Feasibility Study <br /> 9.4.3 Municipal and Other Pumping Coordination....................................39 <br /> 9.4.3.1 Effectiveness ............................................................................39 <br /> 9.4.3.2 Implementability........................................................................39 <br /> 9.4.3.3 Relative Cost ............................................................................39 <br /> 9.4.4 Control, Monitoring, and Well Installation ........................................39 <br /> 9.4.4.1 Effectiveness ............................................................................40 <br /> 9.4.4.2 Implementability........................................................................40 <br /> 9.4.4.3 Relative Cost ............................................................................40 <br /> 9.4.5 Conclusion ......................................................................................40 <br /> 10 Development and Screening of Alternatives for Impacted Areas ..........40 <br /> 10.1 Individual Analysis of Alternatives..........................................................40 <br /> 10.1.1 Alternative 1 .................................................................................40 <br /> 10.1.1.1 Description ...............................................................................40 <br /> 10.1.1.2 Assessment .............................................................................40 <br /> 10.1.2 Alternative 2 .................................................................................41 <br /> 10.1.2.1 Description ...............................................................................41 <br /> 10.1.2.2 Assessment .............................................................................41 <br /> 10.1.3 Alternative 3.................................................................................42 <br /> 10.1.3.1 Description ...............................................................................42 <br /> 10.1.3.2 Assessment .............................................................................42 <br /> 10.1.4 Alternative 4.................................................................................43 <br /> 10.1.4.1 Description ...............................................................................43 <br /> 10.1.4.2 Assessment .............................................................................44 <br /> 11 Comparative Analysis of Alternatives ....................................................45 <br /> 11.1 Overall Protection of Human Health and the Environment.....................45 <br /> 11.2 Compliance with State and Federal Regulations ...................................45 <br /> 11.3 Long-Term Effectiveness and Permanence...........................................45 <br /> 11.4 Reduction in Toxicity, Mobility, and Volume...........................................45 <br /> 11.5 Short-Term Effectiveness ......................................................................46 <br /> 11.6 Implementability.....................................................................................46 <br /> 11.7 Cost .......................................................................................................46 <br /> 11.8 Recommendations.................................................................................46 <br /> 12 Endnotes ...............................................................................................48 <br />
The URL can be used to link to this page
Your browser does not support the video tag.